Literature DB >> 34704673

Ivacaftor restores delayed mucociliary transport caused by Pseudomonas aeruginosa-induced acquired cystic fibrosis transmembrane conductance regulator dysfunction in rabbit nasal epithelia.

Do-Yeon Cho1,2,3, Shaoyan Zhang1,2, Daniel F Skinner1,2, Dong Jin Lim1,2, Catherine Banks1, Jessica W Grayson1, Guillermo J Tearney4,5, Steven M Rowe2,6,7, Bradford A Woodworth1,2.   

Abstract

BACKGROUND: Abnormal chloride (Cl- ) transport dehydrates airway surface liquid (ASL) in sinonasal epithelium leading to mucus stasis and chronic rhinosinusitis. As an experimental epithelium, rabbit tissue provides an excellent representation of human sinus disease, and the rabbit sinusitis model is both established and well suited for therapeutic interventions in vivo. Our objective in this study was to evaluate whether ivacaftor reverses the consequences of Pseudomonas aeruginosa-induced acquired cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction.
METHODS: Rabbit nasal cavities were assessed for responsiveness to ivacaftor in vivo (by nasal potential difference [NPD] assay). Rabbit nasal epithelial (RNE) cultures were incubated with an ultrafiltrate of P aeruginosa (PAO1 strain) for 4 hours and tested for acquired CFTR dysfunction. Markers of mucociliary function, including airway surface liquid depth (ASL), periciliary liquid depth (PCL), ciliary beat frequency (CBF), and mucociliary transport (MCT), were measured by micro-optical coherence tomography (μOCT) after PAO1 and/or ivacaftor incubation.
RESULTS: Ivacaftor resulted in a significant mean NPD polarization of 21.8 ± 2.1 mV, which was significantly greater than that seen in the low Cl- control (12.9 ± 1.3; p = 0.01). PAO1 exposure induced a state of acquired CFTR dysfunction in rabbit nasal epithelium as measured by forskolin-stimulated short-circuit current (ISC ) (control, 37.0 ± 1.1 μA/cm2 ; PAO1, 24.4 ± 1.1 μA/cm2 ; p < 0.001). RNE cultures exposed to PAO1 had inhibited mucociliary function, whereas coincubation with ivacaftor restored mucociliary clearance, as measured by μOCT.
CONCLUSION: In rabbit nasal epithelium, ivacaftor robustly stimulates CFTR-mediated Cl- secretion and normalizes ASL and CBF in PAO1-induced acquired CFTR dysfunction. Preclinical testing of CFTR potentiators as therapy for P aeruginosa rabbit sinusitis is planned.
© 2021 ARS-AAOA, LLC.

Entities:  

Keywords:  CFTR; chronic rhinosinusitis; chronic sinusitis; cystic fibrosis; ivacaftor; micro-optical coherence tomography; mucociliary clearance; mucociliary transport; sinusitis

Mesh:

Substances:

Year:  2021        PMID: 34704673      PMCID: PMC9038953          DOI: 10.1002/alr.22907

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   5.426


  47 in total

1.  Quercetin increases cystic fibrosis transmembrane conductance regulator-mediated chloride transport and ciliary beat frequency: therapeutic implications for chronic rhinosinusitis.

Authors:  Shaoyan Zhang; Nicholas Smith; Daniel Schuster; Christopher Azbell; Eric J Sorscher; Steven M Rowe; Bradford A Woodworth
Journal:  Am J Rhinol Allergy       Date:  2011 Sep-Oct       Impact factor: 2.467

2.  The bioflavonoid compound, sinupret, stimulates transepithelial chloride transport in vitro and in vivo.

Authors:  Frank Virgin; Shaoyan Zhang; Daniel Schuster; Christopher Azbell; James Fortenberry; Eric J Sorscher; Bradford A Woodworth
Journal:  Laryngoscope       Date:  2010-05       Impact factor: 3.325

3.  Resveratrol and ivacaftor are additive G551D CFTR-channel potentiators: therapeutic implications for cystic fibrosis sinus disease.

Authors:  Do-Yeon Cho; Shaoyan Zhang; Ahmed Lazrak; Jessica W Grayson; Jaime A Peña Garcia; Daniel F Skinner; Dong Jin Lim; Calvin Mackey; Catherine Banks; Sadis Matalon; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2018-08-27       Impact factor: 3.858

4.  Influenza virus M2 targets cystic fibrosis transmembrane conductance regulator for lysosomal degradation during viral infection.

Authors:  James David Londino; Ahmed Lazrak; James W Noah; Saurabh Aggarwal; Vedrana Bali; Bradford A Woodworth; Zsuzsanna Bebok; Sadis Matalon
Journal:  FASEB J       Date:  2015-03-20       Impact factor: 5.191

5.  Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770.

Authors:  Fredrick Van Goor; Sabine Hadida; Peter D J Grootenhuis; Bill Burton; Dong Cao; Tim Neuberger; Amanda Turnbull; Ashvani Singh; John Joubran; Anna Hazlewood; Jinglan Zhou; Jason McCartney; Vijayalaksmi Arumugam; Caroline Decker; Jennifer Yang; Chris Young; Eric R Olson; Jeffery J Wine; Raymond A Frizzell; Melissa Ashlock; Paul Negulescu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-21       Impact factor: 11.205

6.  Porcine nasal epithelial cultures for studies of cystic fibrosis sinusitis.

Authors:  Nichole Dean; Neel K Ranganath; Brandon Jones; Shaoyan Zhang; Daniel Skinner; Steven M Rowe; Eric J Sorscher; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2014-04-14       Impact factor: 3.858

7.  Medical and Surgical Advancements in the Management of Cystic Fibrosis Chronic Rhinosinusitis.

Authors:  Kiranya E Tipirneni; Bradford A Woodworth
Journal:  Curr Otorhinolaryngol Rep       Date:  2017-02-21

8.  LPS decreases CFTR open probability and mucociliary transport through generation of reactive oxygen species.

Authors:  Do Yeon Cho; Shaoyan Zhang; Ahmed Lazrak; Daniel Skinner; Harrison M Thompson; Jessica Grayson; Purushotham Guroji; Saurabh Aggarwal; Zsuzsanna Bebok; Steven M Rowe; Sadis Matalon; Eric J Sorscher; Bradford A Woodworth
Journal:  Redox Biol       Date:  2021-04-30       Impact factor: 10.787

9.  IP-10 is a potential biomarker of cystic fibrosis acute pulmonary exacerbations.

Authors:  George M Solomon; Carla Frederick; Shaoyan Zhang; Amit Gaggar; Tom Harris; Bradford A Woodworth; Chad Steele; Steven M Rowe
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

10.  Resveratrol enhances airway surface liquid depth in sinonasal epithelium by increasing cystic fibrosis transmembrane conductance regulator open probability.

Authors:  Shaoyan Zhang; Angela C Blount; Carmel M McNicholas; Daniel F Skinner; Michael Chestnut; John C Kappes; Eric J Sorscher; Bradford A Woodworth
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

View more
  1 in total

Review 1.  Animal models of cystic fibrosis in the era of highly effective modulator therapies.

Authors:  Barbara R Grubb; Alessandra Livraghi-Butrico
Journal:  Curr Opin Pharmacol       Date:  2022-05-13       Impact factor: 4.768

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.